ESTIMATING RADIATION ABSORBED DOSE OF INDIVIDUALS NEARBY 131I-TREATED HYPERTHYROID PATIENTS

被引:6
作者
Cui, Songye [1 ,2 ]
Jiao, Ling [1 ,2 ]
Tan, Jian [3 ]
Zhang, Guizhi [3 ]
Zhang, Haiying [1 ,2 ]
Long, Wei [1 ,2 ]
Fan, Saijun [1 ,2 ]
Zhang, Wenyi [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Inst Radiat Med, Tianjin 300192, Peoples R China
[2] Peking Union Med Coll, Tianjin 300192, Peoples R China
[3] Tianjin Med Univ, Gen Hosp, Dept Nucl Med, Tianjin, Peoples R China
来源
HEALTH PHYSICS | 2014年 / 106卷 / 03期
关键词
I-131; radiation dose; risk estimates; thyroid; RECEIVING I-131 THERAPY; THYROID-CANCER; SAFETY CONSIDERATIONS; ADULT PATIENTS; RATES;
D O I
10.1097/HP.0b013e3182a1c8d5
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The purpose of this study was to systematically provide a database for estimating radiation dose of individuals nearby I-131-treated hyperthyroid patients. External dose rates were measured on 48 hyperthyroid patients using a survey meter in front of patients' thyroid glands. The initial measurement was recorded within 30 min post radioiodine administration at 0.3 m, 0.6 m, 1 m, and 2 m. Follow-up measurements were carried out up to 12 d post radioiodine administration. In addition, ambient dose rates of different locations such as wards, patients' washrooms, medical staffs' workplaces, and corridors were also measured. TheNa(131)I treatment dose administered in this study ranged from 74-555 MBq. Significant positive correlation between dose rate at 1 m and the administered dose was found in this study. The normalized external dose rates at 0.3 m were 0.234 mu Sv h(-1) MBq(-1) at 0.5 h, 0.325 mu Sv h(-1) MBq(-1) at 4 h, 0.308 mu Sv h(-1) MBq(-1) at 6 h, 0.301 mu Sv h(-1) MBq(-1) at 24 h, 0.259 mu Sv h(-1) MBq(-1) at 48 h, 0.234 mu Sv h(-1) MBq(-1) at 72 h, 0.224 mu Sv h(-1) MBq(-1) at 96 h, 0.186 mu Sv h(-1) MBq(-1) at 120 h, and 0.158 mu Sv h(-1) MBq(-1) at 144 h, respectively. With these results, the authors estimated radioactive radiation dose for the public and medical staffs near I-131-treated hyperthyroid patients. This study is beneficial for radiation safety decision-making.
引用
收藏
页码:365 / 369
页数:5
相关论文
共 13 条
[1]   What can be expected from nuclear medicine tomorrow? [J].
Barbet, Jacques ;
Kraeber-Bodere, Francoise ;
Chatal, Jean-Francois .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) :483-504
[2]   Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid [J].
Barrington, SF ;
Kettle, AG ;
ODoherty, MJ ;
Wells, CP ;
Somer, EJR ;
Coakley, AJ .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (02) :123-130
[3]  
CULVER CM, 1992, J NUCL MED, V33, P1402
[4]  
CULVER CM, 1991, J NUCL MED, V32, P169
[5]   CONTAMINATION OF HOME-ENVIRONMENT BY PATIENTS TREATED WITH I-131 - INITIAL RESULTS [J].
JACOBSON, AP ;
PLATO, PA ;
TOEROEK, D .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1978, 68 (03) :225-230
[6]   Dosimetry and thyroid cancer: the individual dosage of radioiodine [J].
Lassmann, Michael ;
Reiners, Christoph ;
Luster, Markus .
ENDOCRINE-RELATED CANCER, 2010, 17 (03) :R161-R172
[7]   Radiation exposure rate from 131I-treated hyperthyroid patients -: A dynamic study, with data for up to 42 D post therapy [J].
Mohammadi, H .
HEALTH PHYSICS, 2005, 88 (05) :486-490
[8]   RADIATION-DOSE RATES FROM ADULT PATIENTS UNDERGOING NUCLEAR-MEDICINE INVESTIGATIONS [J].
MOUNTFORD, PJ ;
ODOHERTY, MJ ;
FORGE, NI ;
JEFFRIES, A ;
COAKLEY, AJ .
NUCLEAR MEDICINE COMMUNICATIONS, 1991, 12 (09) :767-777
[9]  
National Council on Radiation Protection and Measurements, 2006, 155 NCRP
[10]  
National Council on Radiation Protection and Measurements, 1983, 73 NCRP